Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsor State
17/10/2018 CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial CIM Registered
05/10/2018 Nimotuzumab cold kit for the immunodiagnosis of solid tumors CIM Registered
28/09/2018 Topic Oleozon in patients with epidermophytosis CPN Registered
15/08/2018 Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III. BIOCEN Registered
08/08/2018 VSSP in metastasic renal cell carcinoma CIM Registered
07/08/2018 AMIGOS-2 study CIGB Registered
07/08/2018 CERVICONC-II-300 study CIGB Registered
03/08/2018 CIMAvax-EGF-Platelets-Adults- Lung Cancer CIM Registered
03/08/2018 HeberNasvac® Phase IV in Chronic Hepatitis B CIGB Registered
02/08/2018 NeuroEPO in stroke CIM Registered
01/08/2018 Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase II CATALYSIS Registered
10/07/2018 A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer. ROCHE Registered
09/07/2018 Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory CIM Registered
14/06/2018 Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II BIOCEN Registered
11/06/2018 Usual treatment plus intra-articular application of bioactive formulation for osteoarthritis SSA Registered
05/06/2018 Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase II CATALYSIS Registered
30/05/2018 Results of an antimicrobial stewardship program CenQfal Registered
30/05/2018 Treatment for maxillary cysts SSA Registered
18/05/2018 Gastricel-I CIDEM Registered
10/05/2018 Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II CATALYSIS Registered